Company Profiles

driven by the PitchBook Platform

Mimetogen Pharmaceuticals

Description

Developer of small molecule drugs for eye treatment. The company is a biotechnology company focused on treatment of dry eye, glaucoma, keratoconus and retinitis pigmentosa.

2005

Founded

PRIVATE

Status

1-10

Employees

Later Stage VC

Latest Deal Type

$800k

Latest Deal Amount

$1.65M

Total Amount Raised

Description

Developer of small molecule drugs for eye treatment. The company is a biotechnology company focused on treatment of dry eye, glaucoma, keratoconus and retinitis pigmentosa.

Website:

www.mimetogen.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Other Pharmaceuticals and Biotechnology
Drug Discovery

Primary Office

1000 de La Gauchetiere Street West Suite 900 Montreal, Quebec H3B 5H4Canada +1 (514) 667-5869
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Mimetogen Pharmaceuticals's full profile, request a free trial.

Mimetogen Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Mimetogen Pharmaceuticals Investors (5)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
iNovia CapitalVenture CapitalMinority000 0000000 0000
Medwell CapitalOtherMinority000 0000000 0000
MSBi ValorisationVenture CapitalMinority000 0000000 0000
Schooner CapitalPE/BuyoutMinority000 0000000 0000
VIMAC VenturesVenture CapitalMinority000 0000000 0000
iNovia Capital Venture Capital
Medwell Capital Other
MSBi Valorisation Venture Capital
Schooner Capital PE/Buyout
VIMAC Ventures Venture Capital

Mimetogen Pharmaceuticals Executive Team (8)

NameTitleBoard
Seat
Contact
Info
Garth Cumberlidge Ph.DCo-Founder, Chief Executive Officer, President & Board Member
Francois MongrainVice President of Finance & Chief Financial Officer
Karen Meerovitch Ph.DSenior Director of Clinical Development
Eric Donnenfeld MDAdvisor
Stephen Pflugfelder MDAdvisor
Garth Cumberlidge Ph.D Co-Founder, Chief Executive Officer, President & Board Member
Francois Mongrain Vice President of Finance & Chief Financial Officer
Karen Meerovitch Ph.D Senior Director of Clinical Development
Eric Donnenfeld MD Advisor
Stephen Pflugfelder MD Advisor

Mimetogen Pharmaceuticals Board Members (4)

NameRepresentingRoleSinceContact
Info
Cédric Bisson MDSelfBoard Member000 0000
Garth Cumberlidge Ph.DMimetogen PharmaceuticalsCo-Founder, Chief Executive Officer, President & Board Member000 0000
Martin Wax MDSelfChairman000 0000
Sena Biswas Ph.DVIMAC VenturesManaging Director, Life Sciences000 0000
Cédric Bisson MD Board Member Self
Garth Cumberlidge Ph.D Co-Founder, Chief Executive Officer, President & Board Member Mimetogen Pharmaceuticals
Martin Wax MD Chairman Self
Sena Biswas Ph.D Managing Director, Life Sciences VIMAC Ventures
Request full access to PitchBook